Abstract: Chorea is a rare complication of polycythemia. We report the case of a 70 year-old woman whose polycythemia vera (PV), with Janus Kinase-2 (JAK2) mutation, presented as chorea. Chorea resolved quickly after hydroxyurea therapy. Keywords: chorea, polycythemia vera, elderly, JAK2
Case report
A 70 year-old woman attended the outpatient clinic of neurology department (Huadong Hospital) with a complaint of involuntary movements in her left limbs during the past 4 days, beginning with involuntary twitching of the muscles in the limbs. A diagnosis of chorea was made and she was treated with haloperidol 2 mg twice a day. One week later, her choreic symptoms had resolved. One month later, she experienced an episode of dizziness, and the next morning involuntary movements reappeared with new symptoms of dysarthria and dysphagia. Five days later, the twitching had escalated to jerking of the muscles which became generalized, extending to the shoulders and face but it ceased during sleep. Her speech and swallowing were moderately affected.
There was no family history of movement disorders, dementia or psychiatric illness, and no medical history of stroke, peripheral vascular disease, metabolic or endocrine disorders, or autoimmune disease. She had otherwise been well except for gingival bleeding as a result of taking aspirin. She was not being treated with chorea-inducing drugs such as antiparkinsonian drugs, amphetamines, tricyclic antidepressants, anticonvulsants, or antipsychotics.
Physical examination showed facial plethora and erythema of the hands with mild clubbing of the fingers but no splenomegaly. Blood pressure was 130/80 mmHg and temperature was 36.5°C. Neurological examination disclosed choreiform movements of the limbs and orofaciolingual muscles with writhing movements of the tongue, grimacing, grunting, and moderately severe dysarthria and dysphagia. All four limbs were hypotonic with decreased tendon reflexes and flexor plantar responses. Peripheral arterial pulses were palpable in all distal extremities. She was in a state of mild euphoria with a mini-mental state examination (Chinese version) score of 29/30. The bone marrow aspirate and trephine biopsy specimens were hypercellular for the patient's age, with biopsy cellularity approximately 80%; erythroid hyperplasia was present. The granulocyte/erythroid (G/E) ratio was 1:2, megakaryocytic 8-10/higher power field (HPF). Reticulin was graded 1 according to a modified Bauermeister scale.
2 Serum erythropoietin was 5.74 mIU/mL (4.3-29 mIU/mL). Results of the following investigations were normal: vitamin B12, calcium concentrations, thyroid function, tests for syphilis and HIV. Retrospective review of laboratory test results revealed an elevated hemoglobin and hematocrit levels 7 months prior to the development of chorea. Apart from mild ischemic white matter lesions, no abnormalities were seen on magnetic resonance imaging. Chest computed tomography demonstrated slight pulmonary arterial dilation. Genetic analysis showed JAK2V617F in her peripheral blood granulocytes. A diagnosis of polycythemia vera was established according to the World Health Organization (WHO) criteria for polycythemia vera (PV). 3 She was treated with hydroxyurea 1,500 mg and clopidogrel 50 mg daily which led to resolution of her chorea within 4 days.
Discussion
Polycythemia occurs more often in men (3:2), but polycythemia chorea is seen predominantly in women (5:2), usually after the age of 50, with an overall prevalence of 1% to 2.5%. Neurologic complications have been reported in up to 80% of untreated PV patients, including headache, vertigo, stroke, visual symptoms, tinnitus, and paresthesia. 4, 5 Chorea can be caused by many conditions such as hereditary, autoimmune and metabolic/toxic factors (Table 1) . [6] [7] [8] [9] [10] In such cases, the onset of chorea can be either abrupt or insidious, and is typically generalized. Careful assessment and investigation leads to diagnosis and treatment of the underlying cause. Chorea is a rare complication of PV (0.5%-5%). PV-associated chorea (PVC) has only rarely been reported as the presenting complaint, primarily in older females, and typically involving the orofaciolingual and appendicular musculature. PVC often resolves with phlebotomy or cytoreductive therapy. 4, 5, 11, 12 The onset of chorea has been linked to worsening hematological values, progression of PV, and the resolution of the chorea has been related to treatment of PV; as in this case. 6 Usually there is no recurrence of chorea or other neurological symptoms after treatment. However, there is a single case report of an elderly woman with subacute hemichorea who was found to have JAK2V617F hematopoiesis but with normal a hematologic profile. 13 The pathophysiology of chorea due to polycythemia is far from clear. Sluggish cerebral blood flow, particularly reduced in the basal ganglia, and impaired oxygen transport probably play an important part in the pathogenesis. 14 The most important determinant of the viscosity of whole blood is the packed cell volume, and an inverse relationship can be shown between cerebral blood flow and packed cell volume. 15 It has also been hypothesized that dopamine receptor hypersensitivity resulting from estrogen deficit in postmenopausal women and, possibly, an excess accumulation of dopamine, due to platelet congestion in cerebral vessels are also reasonable mechanisms. 6, 8, 11 It has also been suggested that the development of PVC is associated with a reversible alteration in the corticobasal ganglia metabolism and disturbed dopaminergic function. 16 We suggest that patients aged over 50 years, especially females, presenting with chorea should have a full blood count to exclude PV. Prompt diagnosis and treatment of PV will lead to resolution of the chorea and reduce the risk of deep vein thrombosis, pulmonary embolism, stroke, and other serious complications. 6 In those with a known diagnosis of PV, the physician should be aware that the onset of chorea usually means that the hematological variables are deteriorating. 
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